{"id":"https://openalex.org/W3136089726","doi":null,"title":"Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i.","display_name":"Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i.","publication_year":2021,"publication_date":"2021-02-01","ids":{"openalex":"https://openalex.org/W3136089726","mag":"3136089726","pmid":"https://pubmed.ncbi.nlm.nih.gov/33753980","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7941065"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7941065","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7941065","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJIFCC","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7941065","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087683648","display_name":"Guillermo Velasco de Cos","orcid":"https://orcid.org/0000-0002-7260-3789","observed_orcids":["https://orcid.org/0000-0002-7260-3789"]},"institutions":[{"id":"https://openalex.org/I4210099858","display_name":"Marqu\u00e9s de Valdecilla University Hospital","ror":"https://ror.org/01w4yqf75","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210099858"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Guillermo Velasco de Cos","raw_affiliation_strings":["Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain","institution_ids":["https://openalex.org/I4210099858"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000125354","display_name":"Mar\u00eda Isabel S\u00e1nchez-Molina Acosta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mar\u00eda Isabel S\u00e1nchez-Molina Acosta","raw_affiliation_strings":["Hospital Comarcal de Laredo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Comarcal de Laredo, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036984329","display_name":"Mar\u00eda Matilde Toval Fern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099858","display_name":"Marqu\u00e9s de Valdecilla University Hospital","ror":"https://ror.org/01w4yqf75","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210099858"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda Matilde Toval Fern\u00e1ndez","raw_affiliation_strings":["Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain","institution_ids":["https://openalex.org/I4210099858"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3434,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.54878429,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"32","issue":"1","first_page":"105","last_page":"110"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.023800000548362732,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11623","display_name":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/euglycemic-diabetic-ketoacidosis","display_name":"euglycemic diabetic ketoacidosis","score":0.9750000238418579},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9850000143051147},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9089999794960022},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9580000042915344},{"id":"https://openalex.org/keywords/drug-induced-ketoacidosis","display_name":"drug-induced ketoacidosis","score":0.8799999952316284},{"id":"https://openalex.org/keywords/coma","display_name":"coma","score":0.6830000281333923},{"id":"https://openalex.org/keywords/intensive-care-unit-admission","display_name":"intensive care unit admission","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C2781283889","wikidata":"https://www.wikidata.org/wiki/Q1130148","display_name":"Diabetic ketoacidosis","level":3,"score":0.8183630704879761},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8175791501998901},{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.6997052431106567},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6631297469139099},{"id":"https://openalex.org/C2775849729","wikidata":"https://www.wikidata.org/wiki/Q1130148","display_name":"Ketoacidosis","level":4,"score":0.6071357727050781},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6054457426071167},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5990577936172485},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5927649140357971},{"id":"https://openalex.org/C2778721985","wikidata":"https://www.wikidata.org/wiki/Q1183680","display_name":"Decompensation","level":2,"score":0.49097493290901184},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.47497862577438354},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.4580693244934082},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.44582968950271606},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.25992363691329956}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:7941065","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7941065","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJIFCC","raw_type":"Text"},{"id":"pmid:33753980","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33753980","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJIFCC","raw_type":"Case Reports"},{"id":"mag:3136089726","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/PMC/PMC7941065","pdf_url":null,"source":{"id":"https://openalex.org/S4306508991","display_name":"EJIFCC","issn_l":"1051-2292","issn":["1051-2292","1650-3414"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"EJIFCC","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7941065","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7941065","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJIFCC","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1834962231","https://openalex.org/W2199724879","https://openalex.org/W2529467621","https://openalex.org/W2620144385","https://openalex.org/W2752336798","https://openalex.org/W2799934550","https://openalex.org/W2972201761","https://openalex.org/W2989169946","https://openalex.org/W3008062346"],"related_works":["https://openalex.org/W3043017237","https://openalex.org/W2623976553","https://openalex.org/W4390239207","https://openalex.org/W4283380938","https://openalex.org/W3207631336","https://openalex.org/W3021706192","https://openalex.org/W4415434632","https://openalex.org/W2895193918","https://openalex.org/W4378348244","https://openalex.org/W7203770115"],"abstract_inverted_index":{"Euglycemic":[0,45],"diabetic":[1],"ketoacidosis":[2],"(euglycemic":[3],"DKA)":[4],"is":[5,47],"a":[6,73,95],"serious":[7],"complication":[8],"of":[9,29,36,72],"diabetes,":[10],"which":[11,64],"can":[12],"occur":[13],"in":[14,54,94],"some":[15],"patients":[16],"treated":[17,81],"with":[18,76,82,97],"oral":[19],"antidiabetics":[20],"called":[21],"sodium-glucose":[22],"co-transporter":[23],"2":[24,78],"inhibitors":[25],"(SGLT2i).":[26],"This":[27],"group":[28],"drugs":[30],"works":[31],"by":[32,49],"increasing":[33],"renal":[34],"excretion":[35],"sodium":[37],"and":[38,84],"glucose,":[39],"thereby":[40],"lowering":[41],"blood":[42,51],"glucose":[43,52],"levels.":[44],"DKA":[46],"characterized":[48],"having":[50],"levels":[53],"the":[55,70,90],"normal":[56],"range,":[57],"usually":[58],"below":[59],"200":[60],"mg/dL":[61],"(11":[62],"mmol/L),":[63],"complicates":[65],"early":[66],"diagnosis.":[67],"We":[68],"present":[69],"case":[71],"67-year-old":[74],"patient":[75],"type":[77],"diabetes":[79],"mellitus,":[80],"metformin":[83],"empagliflozin,":[85],"who":[86],"was":[87],"admitted":[88],"to":[89],"Intensive":[91],"Care":[92],"Unit":[93],"coma":[96],"severe":[98],"ketoacidotic":[99],"decompensation.":[100]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2021-03-29T00:00:00"}